Assessment of Visual Function and Optics in Intraocular Lenses

Cataract Clinical Trial

Official title:

Evaluating Subjective and Objective Performance of Instrumentation Used and Devices Implanted in Cataract Surgery

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT01654159
• Other study ID #: IOL2012
• Status: Enrolling by invitation
• Phase: N/A
• Start date: September 2013
• Est. completion date: December 2024

Study information

• Verified date: July 2023
• Source: Aston University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The main objective of this research is to assess visual function and optical performance of CE marked, implanted intraocular lenses to understand the individual factors that affect their performance and how these may be improved in future designs and to evaluate measurement techniques.

All outcome measures will be captured 3-6 months after surgery

Description:

A cataract occurs when the natural lens of the eye, which plays a major role in the focusing of light and production of sharp visual images, becomes cloudy and hardens, resulting in a loss of visual function. Left untreated, cataracts can cause preventable blindness. During cataract surgery the natural lens is removed and a man-made intraocular lens (IOL) is implanted in its place.

IOL technology has advanced significantly in recent years and as a result the main goal of cataract surgery is no longer simply the successful removal of the cloudy lens and restoration of vision. Providing patients with the best possible refractive outcome and the best possible visual quality is now much more important when assessing surgery outcomes.

Aspheric, multifocal and accommodating IOLs are among the new designs developed to improve visual outcome after cataract surgery. In order to assess the effectiveness of these designs, visual function needs to be evaluated both objectively and subjectively following their implantation. Such evaluation allows the continued evolution of these IOL designs towards optimum. This proposed research study, which aims to assess the visual function and optical performance of new CE marked IOLs after implantation, could significantly contribute to the enhancement and development of improved IOL designs in the future.

We have successfully conducted similar patient trials for the past 5 years. As new IOL designs are constantly being developed, approved and CE marked, this type of research study will always have the potential to offer new information that is not currently available and has not previously been assessed or published and could contribute towards improved IOL designs in the future.

All outcome measures will be captured 3-6 months after surgery

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 500
• Est. completion date: December 2024
• Est. primary completion date: December 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 40 Years to 85 Years

Eligibility

Inclusion Criteria:

• Subjects age between 40-85 years, may be either male or female, and may be of any race (as cataracts rarely occur before the age of 40 and above 85 other ocular pathology is common).

• Subjects requiring cataract surgery.

• Potential for best corrected visual acuity of 6/12 or better (as visual function in these patients will be affected by ocular pathology).

• Subjects with clear intraocular media other than cataract (as assessing cataract).

• General physical and mental condition allowing participation in current study.

• Subjects willing to participate as evidenced by signing the written informed

Exclusion Criteria:

• Prior surgery on the selected eye

• Previous uveitis or trauma to the selected eye, anterior or posterior synechiae

• Potential for best corrected visual acuity worse than 6/12 (since this may indicate other causes of ocular pathology)

• Partial or total paralysis, Parkinsons syndrome, cerebrovascular accident or other condition that could impact on the results of the study

• Subject over 85 years of age (ocular pathology more common in this age group)

• Subjects without adequate physical and mental capacity to enable participation in the study

• Subject unwilling to participate

• Systemic or topical medication known to influence visual function measures

Related Conditions & MeSH terms

• Cataract

Intervention

Procedure:
• Monofocal IOL
Monofocal Intraocular lens will be implanted
• Multifocal IOL
Multifocal IOL will be implanted
• Toric IOL
Toric IOLS will be implanted

Locations

Country	Name	City	State
United Kingdom	Birmingham Midland Eye Centre	Birmingham	West Midlands

Sponsors (1)

Lead Sponsor	Collaborator
Aston University

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Unaided distance and near vision	Visual Acuity (logMAR)	Measured at 3-6 months after surgery
Secondary	Patient Satisfaction	NAVQ score	Measured at 3-6 months after surgery
Secondary	Residual refraction	Autorefraction / subjective refraction	Measured at 3-6 months after surgery
Secondary	Aberrations	Aberrometry	Measured at 3-6 months after surgery
Secondary	Corrected distance and near acuity	Acuity (logMAR)	Measured at 3-6 months after surgery